骨髄移植の世界市場：タイプ別、治療タイプ別、エンドユーザー別、地域別

世界の骨髄移植の市場規模は、2025年には112億米ドルと推定され、2032年には152億6,000万米ドルに達すると予測され、2025年～2032年のCAGRは4.5%で成長する見込みです。

図.骨髄移植市場シェア（%）、2025年、地域別

骨髄移植は、患者の損傷した骨髄や不健康な骨髄の代わりに健康な骨髄幹細胞を注入する処置です。骨髄移植は、白血病、リンパ腫、その他の血液疾患など、さまざまな血液がんの治療に一般的に用いられています。幹細胞は患者から採取する方法（自家移植）とドナーから採取する方法（同種移植）があります。同種移植は、提供された幹細胞が健康な新しい細胞を作り出すことができるため、自家移植に比べて成功率が高いです。しかし、免疫拒絶反応による合併症のリスクも高くなります。移植手術の進歩やドナーとのマッチングの向上により、骨髄移植に対する需要は非常に高まっています。

市場力学：

世界の骨髄移植市場の成長を牽引しているのは、世界中で血液がんやその他の血液疾患の有病率が上昇していることです。WHOが発表したデータによると、2018年には世界で約1,810万人の新たながん患者と960万人のがん死亡者が報告されました。さらに、効果的な代替治療としての移植に対する意識の高まりや、免疫抑制剤の研究開発への投資の増加が市場開拓を後押ししています。しかし、移植手術に伴う高額な費用、適合ドナーの限られた入手可能性、移植後の移植片拒絶反応のリスクが市場成長の妨げとなる可能性があります。また、骨髄の代替療法として末梢血幹細胞が採用されていることも、市場成長の妨げとなっています。幹細胞治療の開発は、近い将来、市場参入者に有利な機会を提供する可能性があります。

本調査の主な特徴

• 本レポートでは、世界の骨髄移植市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模とCAGR%を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の骨髄移植市場の主要企業をプロファイルしています。
• このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
• 世界の骨髄移植市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 利害関係者は、世界の骨髄移植市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の骨髄移植市場：COVID-19パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の骨髄移植市場：タイプ別（2020年～2032年）

• 自家移植
• 同種移植
• その他

第6章 世界の骨髄移植市場：治療タイプ別（2020年～2032年）

• 白血病
• リンパ腫
• 骨髄腫
• 骨髄異形成症候群
• 骨髄増殖性疾患
• 再生不良性貧血
• 固形腫瘍
• 鎌状赤血球貧血
• サラセミア
• その他

第7章 世界の骨髄移植市場：エンドユーザー別（2020年～2032年）

• 病院
• 多診療科クリニック
• 外来手術センター

第8章 世界の骨髄移植市場：地域別（2020年～2032年）

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• 企業プロファイル
  • Merck Millipore Corporation
  • Sanofi-Aventis LLC.
  • AllCells LLC.
  • STEMCELL Technologies
  • ATCC Inc.
  • Hemacare Corporation
  • Cellular Dynamics International
  • ReachBio LLC.
  • Conversant Bio ABM Inc.
  • PromoCell GmbH
  • Cruline Human biospecimen PRO
  • Lifeline Cell Technology
  • Mesoblast Ltd.
  • Actinium Pharmaceuticals, Inc
  • Bluebird Bio, Inc
  • Gilead Sciences, Inc
  • Novartis AG

第10章 アナリストの推奨事項

• 運命の輪
• アナリストの見解
• Coherent Opportunity Map（COM）

第11章 参考文献と調査手法

• 参考文献
• 調査手法

Global Bone Marrow Transplant Market is estimated to be valued at USD 11.20 Bn in 2025 and is expected to reach USD 15.26 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.5% from 2025 to 2032.

Figure. Bone Marrow Transplant Market Share (%), By Region 2025

Bone marrow transplant is a procedure that infuses healthy bone marrow stem cells to replace the damaged or unhealthy bone marrow of a patient. It is commonly used for treating various blood cancers like leukemia, lymphoma and other blood disorders. The stem cells can either be obtained from the patient (autologous transplant) or from a donor (allogeneic transplant). Allogeneic transplants have shown more success rates as compared to autologous as the donated stem cells can produce healthy new cells. However, it also carries higher risks of complications due to immune rejection. With advancements in transplant procedures and better donor matching, there has been huge demand for bone marrow transplants.

Market Dynamics:

Global bone marrow transplant market growth is driven by rising prevalence of blood cancers and other hematological disorders worldwide. According to the data published by WHO, around 18.1 million new cancer cases and 9.6 million cancer deaths were reported in 2018 globally. Furthermore, growing awareness about transplantation as an effective treatment alternative and increasing investment in research & development of immunosuppressant drugs are driving the market growth. However, high costs associated with transplant procedures, limited availability of matched donors, and risks of graft rejection post-transplant can hamper the market growth. Adoption of peripheral blood stem cells as an alternative to bone marrow can also hamper the market growth. The development of stem cell therapies can offer lucrative opportunities for market players in the near future.

Key Features of the Study:

• This report provides in-depth analysis of the global bone marrow transplant market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bone marrow transplant market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include AllCells, ReachBio LLC, Conversant Bio, Cellular Dynamics International, and Takeda Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global bone marrow transplant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bone marrow transplant market

Detailed Segmentation-

• By Type
  • Autologous Transplant
  • Allogenic Transplant
  • Others
• By Treatment Type
  • Leukemia
  • Lymphoma
  • Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Disorders
  • Aplastic Anemia
  • Solid Tumors
  • Sickle cell Anemia
  • Thalassemia
  • Others
• By End User
  • Hospitals
  • Multi-specialty Clinics
  • Ambulatory Surgical Centers
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Merck Millipore Corporation
  • Sanofi-Aventis LLC.
  • AllCells LLC.
  • STEMCELL Technologies
  • ATCC Inc.
  • Hemacare Corporation
  • Cellular Dynamics International
  • ReachBio LLC.
  • Conversant Bio ABM Inc.
  • PromoCell GmbH
  • Cruline Human biospecimen PRO
  • Lifeline Cell Technology
  • Mesoblast Ltd.
  • Actinium Pharmaceuticals, Inc
  • Bluebird Bio, Inc
  • Gilead Sciences, Inc
  • Novartis AG

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Treatment Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Bone Marrow Transplant Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Bone Marrow Transplant Market, By Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Autologous Transplant
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Allogenic Transplant
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Bone Marrow Transplant Market, By Treatment Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Leukemia
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Lymphoma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Myeloma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Myelodysplastic Syndrome
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Myeloproliferative Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Aplastic Anemia
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Solid Tumors
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sickle cell Anemia
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Thalassemia
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Bone Marrow Transplant Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Multi-specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Bone Marrow Transplant Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Merck Millipore Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi-Aventis LLC.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AllCells LLC.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • STEMCELL Technologies
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ATCC Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hemacare Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cellular Dynamics International
  • ReachBio LLC.
  • Conversant Bio ABM Inc.
  • PromoCell GmbH
  • Cruline Human biospecimen PRO
  • Lifeline Cell Technology
  • Mesoblast Ltd.
  • Actinium Pharmaceuticals, Inc
  • Bluebird Bio, Inc
  • Gilead Sciences, Inc
  • Novartis AG

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact

"